Pfizer Shares Drop as It Ends Study of Weight-Loss Pill Due to Patient Side Effects
- Investing News
admin
- 0
- 1 minute read
Pfizer shares lost ground after ending a study of a twice-a-day weight-loss pill because of negative side effects.
Investing News
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-506997606-3aeda39d7c734e459725400f855c816d.jpg "Is Shopping at Big-Box Stores Worth It? Factors to Consider")
Is Shopping at Big-Box Stores Worth It? Factors to Consider:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1169041231-5052d200552d467baab33417938984a3.jpg "10 Low-Risk Income Sources for a Safer Retirement")
10 Low-Risk Income Sources for a Safer Retirement- How to Claim a Dependent on Your Tax Return
Global ETFs slide as investors see Trump tariff policies hurting trade- R-Squared vs. Beta: What’s the Difference?
:max_bytes(150000):strip_icc():format(jpeg)/business-team-investment-entrepreneur-trading-discussing-and-analysis-graph-stock-market-trading-stock-chart-concept-1089940388-acef8549576a4d918cb157c6c88ec8a1.jpg "Introduction to Phantom Stocks and SARs")
Introduction to Phantom Stocks and SARs:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-991180154-aad62bea33e2473a808a24eb81b8e068.jpg "How the Minimum Wage Impacts Unemployment")
How the Minimum Wage Impacts Unemployment- Are All Fixed Costs Considered Sunk Costs?
Trump Media shares gain 40% in overnight trading on Robinhood as Trump leads in election voting
Bank stocks advance in overnight trading as traders bet on less regulation in a Trump presidency